AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Leurotime 22.5 Injection

Prescription Icon
Prescription Required

Marketer

Axiommax Oncology Pvt Ltd

Salt Composition

Leuprolide (22.5mg)

Overview Leurotime 22.5 Injection

Lupron Depot 22.5 mg injection treats prostate cancer, endometriosis (excessive uterine lining growth causing pain, heavy/irregular bleeding), uterine fibroids, and central precocious puberty (early puberty). Administered subcutaneously by a healthcare professional, dosage and frequency depend on the condition and may vary. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse effects. Benefits may not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include decreased sex drive, excessive sweating, tiredness, muscle weakness, and hot flushes. Prolonged use can weaken bones, necessitating vitamin D and calcium supplementation. Amenorrhea (absence of menstruation) for 7-12 weeks is possible; report persistent bleeding. Disclose alcohol consumption, smoking history, and osteoporosis before treatment initiation. Inform your doctor of all other medications, as interactions are possible. This injection is contraindicated during pregnancy and breastfeeding; effective contraception is essential for both partners throughout treatment.

Uses of Leurotime 22.5 Injection

Managing prostate cancer, endometriosis, uterine fibroids, and precocious puberty.

Major Benefits of Leurotime 22.5 Injection:

The medication will be administered by your physician or their qualified nurse; self-medication is strongly discouraged.

Common Side effects of Leurotime 22.5 Injection:

  • Decreased libido
  • Testicular atrophy
  • Increased sweating
  • Fatigue
  • Muscle weakness
  • Erectile dysfunction
  • Hot flashes

How to use Leurotime 22.5 Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Leurotime 22.5 Injection works:

Leurotime 22.5 Injection lowers sex hormone production, specifically testosterone in men and estrogen in women. Its mechanism involves reducing circulating testosterone in males. In females, it suppresses ovarian hormone synthesis, thereby diminishing estrogen levels and impacting menstrual cycles.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Use of alcohol with Leurotime 22.5 Injection requires careful consideration. Seek medical advice before combining them.

PregnancyPregnancyUNSAFE

Administering Leurotime 22.5 Injection during pregnancy poses a substantial risk. Pregnant individuals should consult their physician; research in both animal and human subjects indicates considerable harm to the fetus.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Leurotime 22.5 Injection with breastfeeding are lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Administering Leurotime 22.5 Injection may induce adverse reactions that impair driving capabilities. Refrain from driving or operating equipment if drowsiness, dizziness, or blurred vision occur during treatment with Leurotime 22.5 Injection.

KidneyKidneyCONSULT YOUR DOCTOR

Data regarding Leurotime 22.5 Injection use in individuals with renal impairment is scarce. Seek medical advice from your physician.

LiverLiverCONSULT YOUR DOCTOR

Data regarding Leurotime 22.5 Injection use in patients exhibiting hepatic impairment is scarce. Physician consultation is recommended.

What if you forget to take Leurotime 22.5 Injection :

Omit a Leurotime 22.5 Injection dose? Seek medical advice immediately.

Facts to Know About Leurotime 22.5 Injection

LabelValue
Type of Compound Gonadotropin-releasing hormone agonist
Potential for Dependence None.
Type of Medication OBSTETRIC AND GYNECOLOGICAL

FAQs on Leurotime 22.5 Injection

Leurotime 22.5 Injection is not a chemotherapeutic agent. Instead, it's a synthetic hormonal analog indicated for managing hormone-related disorders in both male and female patients.
Leurotime 22.5 Injection can disrupt menstrual cycles, often resulting in amenorrhea. In some instances, irregular vaginal bleeding may occur. Consult your physician immediately if this happens for evaluation and guidance.
Leurotime 22.5 Injection is a hormonal drug affecting reproductive hormones in women. Its use is contraindicated in pregnant or potentially pregnant women due to the risk of fetal harm and potential miscarriage. Pregnant women, or those planning pregnancy, must disclose this to their physician prior to commencing treatment.
Leurotime 22.5 Injection can negatively impact bone health. Its use may reduce bone mineral density, leading to weakened bones. Prior to treatment initiation in women, bone density evaluation is recommended. Women at higher risk of osteoporosis require close observation and management. Supplemental medications to counter osteoporosis may be prescribed for individuals experiencing bone mineral density reduction.
Leurotime 22.5 Injection can elevate blood sugar, potentially impairing glucose management in diabetic individuals and raising the risk of new-onset diabetes. Regular monitoring of blood glucose and/or HbA1c is crucial to track glucose control. Report any issues to your physician immediately. Diabetic patients using this medication should increase the frequency of their blood sugar checks.
Leurotime 22.5 Injection
14,824
MRP 17,200
13% off